JENNIFER PANGELINAN: Open Payments
NPI 1831571223 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,637 in 37 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $24 · 2025 $6,637
Consulting: $3,600Travel & lodging: $1,750Food & beverage: $1,287
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 16 | $5,917 |
| Medtronic, Inc. | 2 | $161 |
| Merck Sharp & Dohme LLC | 6 | $159 |
| Eisai Inc. | 3 | $92 |
| Pharmacosmos Therapeutics Inc. | 2 | $72 |
| Janssen Biotech, Inc. | 2 | $71 |
| ABBVIE INC. | 2 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33 |
| Azurity Pharmaceuticals, Inc. | 1 | $26 |
| PFIZER INC. | 1 | $26 |
Products named: SYNCHROMEDII, KEYTRUDA, Lenvima, MONOFERRIC, TALVEY, IMBRUVICA, NINLARO, KEYTRUDA QLEX.
Industry payments across NY — which companies pay providers there.
